Showing results (31-40 of 317) with videos related to
Sort By:
Pageof 32
The Journal of Rheumatology|February 24, 2000
Accurately describing changes in disease activity in Systemic Lupus ErythematosusD D Gladman, M B Urowitz, A Kagal, et al.The Journal of Rheumatology|February 7, 1998
Hormone replacement therapy in systemic lupus erythematosusS Kreidstein, M B Urowitz, D D Gladman, et al.Lupus|September 19, 2009
Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosusM Nikpour, D D Gladman, D Ibañez, et al.Lupus|July 18, 2012
SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 yearsZ Touma, D D Gladman, D Ibañez, et al.Lupus|June 5, 2002
The nature and outcome of infection in systemic lupus erythematosusD D Gladman, F Hussain, D Ibañez, et al.Lupus|January 15, 2011
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluationZ Touma, M B Urowitz, D Ibañez, et al.The Journal of Rheumatology|December 1, 1994
Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flaresB A Walz LeBlanc, D D Gladman, M B UrowitzLupus|September 1, 2017
Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritisR Pakchotanon, D D Gladman, J Su, et al.Lupus|July 4, 2001
Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosusP Rahman, D D Gladman, D Ibanez, et al.Annals of the Rheumatic Diseases|January 1, 1992
Peripheral vascular disease in patients with systemic lupus erythematosusJ McDonald, J Stewart, M B Urowitz, et al.Pageof 32